Chronic fatigue syndrome (CFS) is a condition where symptoms are too intense to continue exercise.
A new therapy developed by scientists at the University of Manchester has been hailed as a significant step towards a cure.
Chronic fatigue is a chronic condition that can be debilitating for sufferers and can lead to long-term disability.
Chronic exertion, or over-exertion, can lead a sufferer to suffer from fatigue.
Chronic overwork can lead sufferers to be overworked, and to experience exhaustion and fatigue-related problems.
The team at the Manchester Biomedical Research Institute have developed a new treatment that uses the body’s natural immune system to combat fatigue.
It is a treatment that works by restoring blood flow to the muscles of the body, including the muscles involved in muscle movement.
Chronic exercise can also contribute to fatigue, but the new treatment is believed to work by repairing muscle tissue in the muscles and joints of the patient.
The new treatment, called Myalgic Encephalomyelitis-CoV-19, or ME/CFS, was published in the journal Nature.
The study found that the new therapy reduces symptoms of fatigue by about 60 per cent and helps people feel more rested and less fatigued.
It also boosts muscle strength and endurance.
Dr James Lomax, senior lecturer in exercise science at the university, said: “Myalgic encephalomyeloid encephalopathy (ME/CEC) is an inflammation of the brain that is associated with various illnesses.
“The aim of our study was to develop a new therapeutic approach to improve the quality of life and reduce chronic fatigue in ME/CE sufferers.””
The treatment has been designed to improve cognitive function and the quality and frequency of physical activity, which are critical factors for long-lasting improvements in health.” “
The aim of our study was to develop a new therapeutic approach to improve the quality of life and reduce chronic fatigue in ME/CE sufferers.”
The treatment has been designed to improve cognitive function and the quality and frequency of physical activity, which are critical factors for long-lasting improvements in health.
“Dr Lomacks research was supported by the Wellcome Trust and the Manchester Institute for Cancer Research.
For more on the research, please visit the BBC News site.